Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) as a Neoadjuvant Chemotherapy for Non-metastatic Esophageal Cancer (nMEC)

Objective: Perioperative chemotherapy can potentially downstage esophageal cancer, reducing the risk of early systemic dissemination. One recommended neoadjuvant regimen for managing gastroesophageal junction and esophageal cancer is docetaxel, cisplatin, and 5-fluorouracil (DCF). To address the hig...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Med Res
Главные авторы: Onitilo, Adedayo A., Stankowski-Drengler, Trista J., Shiyanbola, Oyewale, Engel, Jessica, Tanimu, Sabo, Fagbemi, Seth O., Li, Ya-Huei
Формат: Artigo
Язык:Inglês
Опубликовано: Marshfield Clinic 2021
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8231693/
https://ncbi.nlm.nih.gov/pubmed/33789952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3121/cmr.2021.1573
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы